OpenEvidence and Tandem Partner to Streamline Evidence-Based Prescribing

The collaboration aims to improve patient access to medications through data-driven prior authorization processes.

Apr. 2, 2026 at 6:33pm

Got story updates? Submit your updates here. ›

A minimalist, photorealistic studio still life featuring a stack of medical files, a pen, and a tablet device on a clean, monochromatic background, symbolizing the streamlining of the prior authorization process through technology and data-driven insights.A new partnership aims to leverage evidence-based tools and healthcare technology to simplify the prior authorization process for clinicians.Today in Miami

OpenEvidence, a leading provider of evidence-based clinical decision support tools, has announced a strategic partnership with Tandem, a prominent healthcare technology company. The collaboration will focus on streamlining the prior authorization process for prescription medications, leveraging OpenEvidence's data-driven insights to enhance patient access and improve clinical outcomes.

Why it matters

The prior authorization process can often be a significant barrier to timely and appropriate medication access for patients. By combining OpenEvidence's evidence-based prescribing recommendations with Tandem's technology platform, this partnership aims to create a more efficient and transparent prior authorization system, ultimately benefiting both healthcare providers and their patients.

The details

Through the partnership, OpenEvidence's clinical decision support tools will be integrated into Tandem's platform, allowing healthcare providers to access real-time, evidence-based guidance during the prescription process. This integration will enable more informed decision-making, streamlining the prior authorization workflow and reducing administrative burdens for healthcare organizations.

  • The partnership was announced on April 2, 2026.

The players

OpenEvidence

A leading provider of evidence-based clinical decision support tools that help healthcare providers make more informed prescribing decisions.

Tandem

A prominent healthcare technology company that offers solutions to streamline administrative processes, including the prior authorization workflow.

Got photos? Submit your photos here. ›

What they’re saying

“This partnership with Tandem represents a significant step forward in our mission to improve patient access to evidence-based care. By integrating our clinical decision support tools into their platform, we can empower providers to make more informed prescribing decisions and navigate the prior authorization process more efficiently.”

— Dr. Emily Walters, Chief Medical Officer, OpenEvidence

“Streamlining the prior authorization process is a critical challenge facing the healthcare industry. By collaborating with OpenEvidence, we can leverage their clinical expertise and data-driven insights to create a more transparent and efficient system, ultimately benefiting patients and providers alike.”

— John Simmons, CEO, Tandem

What’s next

The partnership is expected to roll out its integrated solution to healthcare providers in the coming months, with the goal of improving patient access to necessary medications and reducing administrative burdens for healthcare organizations.

The takeaway

This partnership between OpenEvidence and Tandem represents a significant step forward in addressing the longstanding challenges of the prior authorization process. By combining evidence-based clinical decision support with streamlined technology, the collaboration aims to create a more efficient and transparent system that ultimately benefits both healthcare providers and their patients.